{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:34:25Z","timestamp":1793424865017,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41380-026-03535-1","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:07:04Z","timestamp":1774868824000},"page":"4525-4534","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Circuit-targeted modulation of anxiety symptoms in individuals with major depression: A randomized head-to-head TMS trial"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9185-0427","authenticated-orcid":false,"given":"Joseph J.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0306-3018","authenticated-orcid":false,"given":"Summer","family":"Frandsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia R.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Drew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dania","family":"Haj-Darwish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Jabbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Leach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8345-5470","authenticated-orcid":false,"given":"Stephan","family":"Palm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Sanderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuella","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lera","family":"Sterina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Chiulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Barantono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Gonsalvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2651-9754","authenticated-orcid":false,"given":"Stanley","family":"Lyndon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel B.","family":"Snider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8848-6399","authenticated-orcid":false,"given":"Michael D.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0967-9289","authenticated-orcid":false,"given":"Shan H.","family":"Siddiqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"3535_CR1","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJMp1500523","volume":"372","author":"FS Collins","year":"2015","unstructured":"Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372:793\u20135.","journal-title":"N Engl J Med"},{"key":"3535_CR2","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.biopsych.2023.11.013","volume":"95","author":"RFH Cash","year":"2024","unstructured":"Cash RFH, Zalesky A. Personalized and circuit-based transcranial magnetic stimulation: evidence, controversies, and opportunities. Biol Psychiatry. 2024;95:510\u201322.","journal-title":"Biol Psychiatry"},{"key":"3535_CR3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1176\/appi.ajp.2019.19090915","volume":"177","author":"SH Siddiqi","year":"2020","unstructured":"Siddiqi SH, Taylor SF, Cooke D, Pascual-Leone A, George MS, Fox MD. Distinct symptom-specific treatment targets for circuit-based neuromodulation. Am J Psychiatry. 2020;177:435\u201346.","journal-title":"Am J Psychiatry"},{"key":"3535_CR4","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1152\/jn.00338.2011","volume":"106","author":"BT Yeo","year":"2011","unstructured":"Yeo BT, Krienen FM, Sepulcre J, Sabuncu MR, Lashkari D, Hollinshead M, et al. The organization of the human cerebral cortex estimated by intrinsic functional connectivity. J Neurophysiol. 2011;106:1125\u201365.","journal-title":"J Neurophysiol"},{"key":"3535_CR5","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ijsu.2011.09.004","volume":"9","author":"KF Schulz","year":"2011","unstructured":"Schulz KF, Altman DG, Moher D. Group C. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int J Surg. 2011;9:672\u20137.","journal-title":"Int J Surg"},{"key":"3535_CR6","volume-title":"Beck Anxiety Inventory manual","author":"AT Beck","year":"1993","unstructured":"Beck AT, Steer RA. Beck Anxiety Inventory manual. San Antonio, TX: Psychological Corporation; 1993."},{"key":"3535_CR7","doi-asserted-by":"crossref","unstructured":"Kane G, L Meade N. Ratio Analysis Using Rank Transformation, vol. 101998, 59-74pp.","DOI":"10.1023\/A:1008248130384"},{"key":"3535_CR8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1176\/appi.ajp.2019.19090915","volume":"177","author":"SH Siddiqi","year":"2020","unstructured":"Siddiqi SH, Taylor SF, Cooke DC, Pascual-Leone A, George MS, Fox MD. Distinct symptom-specific treatment targets for circuit-based neuromodulation. American Journal of Psychiatry. 2020;177:435\u201346.","journal-title":"American Journal of Psychiatry"},{"key":"3535_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1023\/A:1008248130384","volume":"10","author":"G Kane","year":"1998","unstructured":"Kane G, Meade N. Ratio analysis using rank transformation. Review of Quantitative Finance and Accounting. 1998;10:59\u201374.","journal-title":"Review of Quantitative Finance and Accounting"},{"key":"3535_CR10","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.neuroimage.2016.08.032","volume":"146","author":"EM Gordon","year":"2017","unstructured":"Gordon EM, Laumann TO, Adeyemo B, Gilmore AW, Nelson SM, Dosenbach NUF, et al. Individual-specific features of brain systems identified with resting state functional correlations. Neuroimage. 2017;146:918\u201339.","journal-title":"Neuroimage"},{"key":"3535_CR11","doi-asserted-by":"publisher","first-page":"204512532110499","DOI":"10.1177\/20451253211049921","volume":"11","author":"NJ Petrosino","year":"2021","unstructured":"Petrosino NJ, Cosmo C, Berlow YA, Zandvakili A, van \u2018t Wout-Frank M, Philip NS. Transcranial magnetic stimulation for post-traumatic stress disorder. Ther Adv Psychopharmacol. 2021;11:20451253211049921.","journal-title":"Ther Adv Psychopharmacol"},{"key":"3535_CR12","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/da.21969","volume":"29","author":"LL Carpenter","year":"2012","unstructured":"Carpenter LL, Janicak PG, Aaronson ST, Boyadjis T, Brock DG, Cook IA, et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depress Anxiety. 2012;29:587\u201396.","journal-title":"Depress Anxiety"},{"key":"3535_CR13","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.clinph.2024.12.015","volume":"170","author":"NT Trapp","year":"2024","unstructured":"Trapp NT, Purgianto A, Taylor JJ, Singh MK, Oberman LM, Mickey BJ, et al. Consensus review and considerations on TMS to treat depression: a comprehensive update endorsed by the national network of depression centers, the clinical TMS society, and the international federation of clinical neurophysiology. Clin Neurophysiol. 2024;170:206\u201333.","journal-title":"Clin Neurophysiol"},{"key":"3535_CR14","doi-asserted-by":"publisher","first-page":"22m14571","DOI":"10.4088\/JCP.22m14571","volume":"84","author":"TM Hutton","year":"2023","unstructured":"Hutton TM, Aaronson ST, Carpenter LL, Pages K, West WS, Kraemer C, et al. The anxiolytic and antidepressant effects of transcranial magnetic stimulation in patients with anxious depression. J Clin Psychiatry. 2023;84:22m14571.","journal-title":"J Clin Psychiatry"},{"key":"3535_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.brs.2019.10.020","volume":"13","author":"K Dunlop","year":"2020","unstructured":"Dunlop K, Sheen J, Schulze L, Fettes P, Mansouri F, Feffer K, et al. Dorsomedial prefrontal cortex repetitive transcranial magnetic stimulation for treatment-refractory major depressive disorder: A three-arm, blinded, randomized controlled trial. Brain Stimul. 2020;13:337\u201340.","journal-title":"Brain Stimul"},{"key":"3535_CR16","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.brs.2016.05.010","volume":"9","author":"A Mir-Moghtadaei","year":"2016","unstructured":"Mir-Moghtadaei A, Giacobbe P, Daskalakis ZJ, Blumberger DM, Downar J. Validation of a 25% nasion-inion heuristic for locating the dorsomedial prefrontal cortex for repetitive transcranial magnetic stimulation. Brain Stimul. 2016;9:793\u20135.","journal-title":"Brain Stimul"},{"key":"3535_CR17","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.brs.2023.09.006","volume":"16","author":"NT Trapp","year":"2023","unstructured":"Trapp NT, Pace BD, Neisewander B, Ten Eyck P, Boes AD. A randomized trial comparing beam F3 and 5.5 cm targeting in rTMS treatment of depression demonstrates similar effectiveness. Brain Stimul. 2023;16:1392\u20131400.","journal-title":"Brain Stimul"},{"key":"3535_CR18","doi-asserted-by":"publisher","first-page":"e165271","DOI":"10.1172\/jci.insight.165271","volume":"8","author":"A Zangen","year":"2023","unstructured":"Zangen A, Zibman S, Tendler A, Barnea-Ygael N, Alyagon U, Blumberger DM, et al. Pursuing personalized medicine for depression by targeting the lateral or medial prefrontal cortex with deep TMS. JCI Insight. 2023;8:e165271.","journal-title":"JCI Insight"},{"key":"3535_CR19","doi-asserted-by":"crossref","unstructured":"Siddiqi SH, Schaper F, Horn A, Hsu J, Padmanabhan JL, Brodtmann A, et al. Brain stimulation and brain lesions converge on common causal circuits in neuropsychiatric disease. Nat Hum Behav 2021;5:1707\u201316.","DOI":"10.1038\/s41562-021-01161-1"},{"key":"3535_CR20","doi-asserted-by":"crossref","unstructured":"Baldi S, Chiulli N, Palm S, Frandsen S, Pell GS, Zibman S, et al. Targeting depression circuitry with H1 coil Transcranial Magnetic Stimulation: a retrospective circuit mapping study. Neuropsychopharmacology. 2025.","DOI":"10.1038\/s41386-025-02157-5"},{"key":"3535_CR21","doi-asserted-by":"crossref","unstructured":"Siddiqi SH, Klingbeil J, Webler R, Kratter IH, Blumberger DM, Fox MD, et al. Causal network localization of brain stimulation targets for trait anxiety. Res Sq. 2024.","DOI":"10.21203\/rs.3.rs-4221074\/v1"},{"key":"3535_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.24","volume":"3","author":"MG Craske","year":"2017","unstructured":"Craske MG, Stein MB, Eley TC, Milad MR, Holmes A, Rapee RM, et al. Anxiety disorders. Nat Rev Dis Primers. 2017;3:17024.","journal-title":"Nat Rev Dis Primers"},{"key":"3535_CR23","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/sj.mp.4001852","volume":"11","author":"A Bystritsky","year":"2006","unstructured":"Bystritsky A. Treatment-resistant anxiety disorders. Mol Psychiatry. 2006;11:805\u201314.","journal-title":"Mol Psychiatry"},{"key":"3535_CR24","doi-asserted-by":"crossref","unstructured":"Diagnostic and statistical manual of mental disorders : DSM-5. American Psychiatric Association: Arlington, VA, 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"3535_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/1520-6394(2000)12:1+<69::AID-DA9>3.0.CO;2-K","volume":"12","author":"J Kaufman","year":"2000","unstructured":"Kaufman J, Charney D. Comorbidity of mood and anxiety disorders. Depress Anxiety. 2000;12:69\u201376.","journal-title":"Depress Anxiety"},{"key":"3535_CR26","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1176\/appi.ajp.159.3.469","volume":"159","author":"M Zimmerman","year":"2002","unstructured":"Zimmerman M, Mattia JI, Posternak MA. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry. 2002;159:469\u201373.","journal-title":"Am J Psychiatry"},{"key":"3535_CR27","doi-asserted-by":"publisher","first-page":"100349","DOI":"10.1016\/j.eclinm.2020.100349","volume":"22","author":"AP Trevizol","year":"2020","unstructured":"Trevizol AP, Downar J, Vila-Rodriguez F, Thorpe KE, Daskalakis ZJ, Blumberger DM. Predictors of remission after repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: An analysis from the randomised non-inferiority THREE-D trial. EClinicalMedicine. 2020;22:100349.","journal-title":"EClinicalMedicine"},{"key":"3535_CR28","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/npp.2008.118","volume":"34","author":"SH Lisanby","year":"2009","unstructured":"Lisanby SH, Husain MM, Rosenquist PB, Maixner D, Gutierrez R, Krystal A, et al. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology. 2009;34:522\u201334.","journal-title":"Neuropsychopharmacology"},{"key":"3535_CR29","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3390\/jcm11041015","volume":"11","author":"GS Pell","year":"2022","unstructured":"Pell GS, Harmelech T, Zibman S, Roth Y, Tendler A, Zangen A. Efficacy of Deep TMS with the H1 Coil for Anxious Depression. J Clin Med. 2022;11:1015.","journal-title":"J Clin Med"},{"key":"3535_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jad.2020.08.005","volume":"277","author":"HA Sackeim","year":"2020","unstructured":"Sackeim HA, Aaronson ST, Carpenter LL, Hutton TM, Mina M, Pages K, et al. Clinical outcomes in a large registry of patients with major depressive disorder treated with Transcranial Magnetic Stimulation. J Affect Disord. 2020;277:65\u201374.","journal-title":"J Affect Disord"},{"key":"3535_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2025.1494811","volume":"16","author":"T Caussat","year":"2025","unstructured":"Caussat T, Blair B, Oberman LM. Effect of TMS laterality on clinical outcomes in treatment resistant depression patients with comorbid anxiety - a retrospective study. Front Psychiatry. 2025;16:1494811.","journal-title":"Front Psychiatry"},{"key":"3535_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11126-023-10062-7","volume":"95","author":"RM Allen","year":"2024","unstructured":"Allen RM, Scanlan JM, Gama-Chonlon L. Bilateral rTMS shows no advantage in depression nor in comorbid depression and anxiety: a naturalistic study. Psychiatr Q. 2024;95:107\u201320.","journal-title":"Psychiatr Q"},{"key":"3535_CR33","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.brs.2022.01.006","volume":"15","author":"ST Aaronson","year":"2022","unstructured":"Aaronson ST, Carpenter LL, Hutton TM, Kraus S, Mina M, Pages K, et al. Comparison of clinical outcomes with left unilateral and sequential bilateral Transcranial Magnetic Stimulation (TMS) treatment of major depressive disorder in a large patient registry. Brain Stimul. 2022;15:326\u201336.","journal-title":"Brain Stimul"},{"key":"3535_CR34","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/da.22894","volume":"36","author":"L Chen","year":"2019","unstructured":"Chen L, Hudaib AR, Hoy KE, Fitzgerald PB. Is rTMS effective for anxiety symptoms in major depressive disorder? An efficacy analysis comparing left-sided high-frequency, right-sided low-frequency, and sequential bilateral rTMS protocols. Depress Anxiety. 2019;36:723\u201331.","journal-title":"Depress Anxiety"},{"key":"3535_CR35","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.psychres.2014.05.010","volume":"219","author":"JJ Chen","year":"2014","unstructured":"Chen JJ, Liu Z, Zhu D, Li Q, Zhang H, Huang H, et al. Bilateral vs. unilateral repetitive transcranial magnetic stimulation in treating major depression: a meta-analysis of randomized controlled trials. Psychiatry Res. 2014;219:51\u201357.","journal-title":"Psychiatry Res"},{"key":"3535_CR36","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1056\/NEJMra1706158","volume":"379","author":"MD Fox","year":"2018","unstructured":"Fox MD. Mapping Symptoms to Brain Networks with the Human Connectome. N Engl J Med. 2018;379:2237\u201345.","journal-title":"N Engl J Med"},{"key":"3535_CR37","doi-asserted-by":"crossref","unstructured":"Siddiqi SH, Khosravani S, Rolston JD, Fox MD. The future of brain circuit-targeted therapeutics. Neuropsychopharmacology 2024;49:179\u201388.","DOI":"10.1038\/s41386-023-01670-9"},{"key":"3535_CR38","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41583-022-00583-8","volume":"23","author":"SH Siddiqi","year":"2022","unstructured":"Siddiqi SH, Kording KP, Parvizi J, Fox MD. Causal mapping of human brain function. Nat Rev Neurosci. 2022;23:361\u201375.","journal-title":"Nat Rev Neurosci"},{"key":"3535_CR39","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1586\/ern.10.156","volume":"10","author":"MS Okun","year":"2010","unstructured":"Okun MS, Foote KD. Parkinson\u2019s disease DBS: what, when, who and why? The time has come to tailor DBS targets. Expert Rev Neurother. 2010;10:1847\u201357.","journal-title":"Expert Rev Neurother"},{"key":"3535_CR40","doi-asserted-by":"publisher","first-page":"S184","DOI":"10.21037\/atm.2019.07.65","volume":"7","author":"JA Barcia","year":"2019","unstructured":"Barcia JA, Reneses B, Nombela C. Precision surgery for obsessive compulsive disorder-which is the proper target? Ann Transl Med. 2019;7:S184.","journal-title":"Ann Transl Med"},{"key":"3535_CR41","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.biopsych.2019.03.969","volume":"85","author":"V Voon","year":"2019","unstructured":"Voon V. Toward precision medicine: prediction of deep brain stimulation targets of the ventral internal capsule for obsessive-compulsive disorder. Biol Psychiatry. 2019;85:708\u201310.","journal-title":"Biol Psychiatry"},{"key":"3535_CR42","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.biopsych.2019.01.017","volume":"85","author":"H Tyagi","year":"2019","unstructured":"Tyagi H, Apergis-Schoute AM, Akram H, Foltynie T, Limousin P, Drummond LM, et al. A randomized trial directly comparing ventral capsule and anteromedial subthalamic nucleus stimulation in obsessive-compulsive disorder: clinical and imaging evidence for dissociable effects. Biol Psychiatry. 2019;85:726\u201334.","journal-title":"Biol Psychiatry"},{"key":"3535_CR43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ana.24974","volume":"82","author":"A Horn","year":"2017","unstructured":"Horn A, Reich M, Vorwerk J, Li N, Wenzel G, Fang Q, et al. Connectivity predicts deep brain stimulation outcome in parkinson disease. Ann Neurol. 2017;82:67\u201378.","journal-title":"Ann Neurol"},{"key":"3535_CR44","doi-asserted-by":"crossref","unstructured":"Cole EJ, Phillips AL, Bentzley BS, Stimpson KH, Nejad R, Barmak F, et al. Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial. Am J Psychiatry 2022;179:132\u201341.","DOI":"10.1176\/appi.ajp.2021.20101429"},{"key":"3535_CR45","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nrrheum.2015.30","volume":"11","author":"K Yoshida","year":"2015","unstructured":"Yoshida K, Solomon DH, Kim SC. Active-comparator design and new-user design in observational studies. Nat Rev Rheumatol. 2015;11:437\u201341.","journal-title":"Nat Rev Rheumatol"},{"key":"3535_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/2193-1801-3-740","volume":"3","author":"S Fukunaga","year":"2014","unstructured":"Fukunaga S, Kusama M, Ono S. The effect size, study design, and development experience in commercially sponsored studies for new drug applications in approved drugs. Springerplus. 2014;3:740.","journal-title":"Springerplus"},{"key":"3535_CR47","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.4088\/JCP.10m06089whi","volume":"72","author":"AC Leon","year":"2011","unstructured":"Leon AC. Comparative effectiveness clinical trials in psychiatry: superiority, noninferiority, and the role of active comparators. J Clin Psychiatry. 2011;72:1344\u20139.","journal-title":"J Clin Psychiatry"},{"key":"3535_CR48","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S2215-0366(19)30394-3","volume":"6","author":"EH Turner","year":"2019","unstructured":"Turner EH. Esketamine for treatment-resistant depression: seven concerns about efficacy and FDA approval. Lancet Psychiatry. 2019;6:977\u20139.","journal-title":"Lancet Psychiatry"},{"key":"3535_CR49","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/s41386-019-0317-8","volume":"44","author":"ST Wilkinson","year":"2019","unstructured":"Wilkinson ST, Farmer C, Ballard ED, Mathew SJ, Grunebaum MF, Murrough JW, et al. Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant. Neuropsychopharmacology. 2019;44:1233\u20138.","journal-title":"Neuropsychopharmacology"},{"key":"3535_CR50","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1038\/s41380-021-01397-3","volume":"27","author":"MJ Burke","year":"2022","unstructured":"Burke MJ, Romanella SM, Mencarelli L, Greben R, Fox MD, Kaptchuk TJ, et al. Placebo effects and neuromodulation for depression: a meta-analysis and evaluation of shared mechanisms. Mol Psychiatry. 2022;27:1658\u201366.","journal-title":"Mol Psychiatry"},{"key":"3535_CR51","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1056\/NEJMoa2302399","volume":"388","author":"A Anand","year":"2023","unstructured":"Anand A, Mathew SJ, Sanacora G, Murrough JW, Goes FS, Altinay M, et al. Ketamine versus ECT for nonpsychotic treatment-resistant major depression. N Engl J Med. 2023;388:2315\u201325.","journal-title":"N Engl J Med"},{"key":"3535_CR52","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1001\/jamapsychiatry.2023.4599","volume":"81","author":"ZD Deng","year":"2024","unstructured":"Deng ZD, Luber B, McClintock SM, Weiner RD, Husain MM, Lisanby SH. Clinical outcomes of magnetic seizure therapy vs electroconvulsive therapy for major depressive episode: a randomized clinical trial. JAMA Psychiatry. 2024;81:240\u20139.","journal-title":"JAMA Psychiatry"},{"key":"3535_CR53","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.biopsych.2023.11.011","volume":"95","author":"SH Siddiqi","year":"2024","unstructured":"Siddiqi SH, Fox MD. Targeting symptom-specific networks with transcranial magnetic stimulation. Biol Psychiatry. 2024;95:502\u20139.","journal-title":"Biol Psychiatry"},{"key":"3535_CR54","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/archgenpsychiatry.2010.46","volume":"67","author":"MS George","year":"2010","unstructured":"George MS, Lisanby SH, Avery D, McDonald WM, Durkalski V, Pavlicova M, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Archives of general psychiatry. 2010;67:507\u201316.","journal-title":"Archives of general psychiatry"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03535-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03535-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03535-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T18:02:02Z","timestamp":1783965722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03535-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["3535"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03535-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4791291\/v1","asserted-by":"object"}]},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SS: Owner of intellectual property involving the use of brain connectivity to target TMS, scientific consultant for Magnus Medical, investigator-initiated research funding from Neuronetics and BrainsWay, speaking fees from BrainsWay and Otsuka (for PsychU.org), shareholder in BrainsWay (publicly traded) and Magnus Medical (not publicly traded). None of these entities were involved in the present manuscript. MDF: Scientific consultant for Magnus Medical, owns independent intellectual property involving the use of functional connectivity to target TMS. This intellectual property was not used in the present manuscript. All other others deny competing of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}